ClinicalTrialsFinder

Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer Clinical Trials in Shenyang, Liaoning

1 recruitingShenyang, Liaoning, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer

Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd.170 enrolled1 locationNCT07122687